SARS-CoV-2 variant exposures elicit antibody responses with differential cross-neutralization of established and emerging strains including Delta and Omicron is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0.396. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.396
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5UM1AI069496-09
San Francisco Bay Clinical Trials Unit
National Institutes of Health
Grant: 5F31AI150007-03
Identification and Characterization of the Antiviral Response to RSV Infection: A Single Cell Approach
Fields of Study
Keywords
Sustainable Development Goals